Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103592503 | 10359250 | 3 | F | 20160905 | 20140804 | 20160919 | EXP | SE-ROCHE-1440079 | ROCHE | LOMAN N, JOHANSSON I, BJOHLE J, FRISELL J, LEKBERG T, RYDEN L, VON WACHENFELDT A, BERGH J, HATSCHEK T AND HEDENFALK I PRELIMINARY TRANSLATIONAL RESULTS FROM PROMIX, A PHASE II TRIAL OF PREOPERATIVE CHEMOTHERAPY WITH THE ADDITION OF BEVACIZUMAB IN LARGE OPERABLE AND LOCALLY ADVANCED HER2-NEGATIVE BREAST CANCER. CANCER RESEARCH 2015 MAY 01;75 (9S1):-. | 0.00 | F | Y | 0.00000 | 20160919 | MD | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103592503 | 10359250 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | 15 | MG/KG | SOLUTION FOR INFUSION | |||||||
| 103592503 | 10359250 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | U | 0 | 75 | MG/M**2 | ||||||||
| 103592503 | 10359250 | 3 | SS | Epirubicin | EPIRUBICIN | 1 | Unknown | U | 0 | 75 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103592503 | 10359250 | 1 | Breast cancer |
| 103592503 | 10359250 | 2 | Breast cancer |
| 103592503 | 10359250 | 3 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103592503 | 10359250 | OT |
| 103592503 | 10359250 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103592503 | 10359250 | Colitis | |
| 103592503 | 10359250 | Fatigue | |
| 103592503 | 10359250 | Haemorrhage | |
| 103592503 | 10359250 | Hypersensitivity | |
| 103592503 | 10359250 | Liver function test increased | |
| 103592503 | 10359250 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |